Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

994
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
994
Pharmacovigilance01:19

Pharmacovigilance

1.4K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.4K
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

92
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
92
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

55
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
55
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

48
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
48
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

59
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
59

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evolutionarily Conserved and Divergent Mechanisms of Dual Ca <sup>2+</sup> Sensors in Synaptic Vesicle Exocytosis.

bioRxiv : the preprint server for biology·2025
Same author

Rates and Predictors of Follow-Up Care and Treatment Initiation Among Women Veterans After a Positive Alcohol Screen.

Substance use & addiction journal·2025
Same author

Development and initial psychometric properties of the timed upper limb assessment in older adults with Parkinson's.

The British journal of occupational therapy·2025
Same author

Fiduciary assignment as a potential intervention for substance use disorder: a retrospective chart review.

The American journal of drug and alcohol abuse·2024
Same author

The persistent impact of the COVID-19 pandemic on pediatric emergency department visits for suicidal thoughts and behaviors.

Suicide & life-threatening behavior·2023
Same author

Vaping and Mental Health Conditions in Children: An Umbrella Review.

Substance abuse : research and treatment·2023

Related Experiment Video

Updated: Nov 11, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.6K

Prescription Drug Monitoring Program: Access in the First Year.

Mitchell Crawford1,2, Pantea Farahmand3, Erin Kate McShane2

  • 1Harvard Medical School, Boston, Massachusetts.

The American Journal on Addictions
|March 24, 2021
PubMed
Summary

Prescription Drug Monitoring Programs (PDMP) access for opioid prescriptions varied significantly by clinical setting and patient factors. Less than one-third adherence to PDMP access policies highlights a need for improved utilization.

More Related Videos

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

10.0K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.8K

Related Experiment Videos

Last Updated: Nov 11, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.6K
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

10.0K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.8K

Area of Science:

  • Health Services Research
  • Clinical Pharmacy
  • Addiction Medicine

Background:

  • Prescription Drug Monitoring Programs (PDMP) are crucial tools for identifying high-risk prescribing and patient behaviors.
  • Understanding documented PDMP access patterns is essential for optimizing its use in opioid prescribing.

Purpose of the Study:

  • To characterize the factors associated with documented PDMP access among opioid prescriptions.
  • To evaluate PDMP access rates across different clinical settings and patient populations.

Main Methods:

  • A retrospective chart review of 695 opioid prescriptions from inpatient and outpatient settings.
  • Analysis of documented PDMP access, including same-day and within-the-week consultation.
  • Logistic regression modeling to identify predictors of PDMP access.

Main Results:

  • Only one-third of charts documented PDMP access within a week of opioid prescription; 12% on the same day.
  • PDMP access varied significantly by setting, from 10.5% in inpatient medicine to 57% in inpatient psychiatry.
  • Patient factors like acute pain, mental health treatment, and substance use disorders were associated with PDMP access.

Conclusions:

  • PDMP utilization in opioid prescribing is inconsistent and varies widely by clinical specialty and setting.
  • Current adherence to PDMP access policies is suboptimal, necessitating further interventions to improve consistent use.